COO
iOmx AG, Germany
Dr. sc. nat. ETH Hannes Loferer (PhD)
PhD Microbiology (ETH Zürich, 1994, awarded w. ETH Medal) with 28 years of industry experience.
Oncology drug development leader with programs ranging from first-in-human entries to readiness for first marketing authorization
Project and portfolio management professional
Large pharma, established biotech and start-up experience
Professional Experience
iOmx Therapeutics AG (since 2018)
Chief Operations Officer, from April 2023
Senior Vice President and Head of Project Management, April 2021 – March 2023
Vice President and Head of Project Management, August 2018 – March 2021
Sotio A.S., Prague, Czech Republic (February 2017- July 2018)
Established biotech with early and late-stage clinical portfolio
VP and Head of Project Management, Reporting to CEO
Onconova Europe GmbH, Munich, Germany (January 2013-November 2016)
(wholly owned subsidiary of Onconova Therapeutics Inc, Princeton/NJ, USA)
Established biotech with and late-stage clinical portfolio. US headquarter
Vice President, Project Planning & Portfolio Management, Reporting to President R&D
Agennix AG, Martinsried, Germany (2009-2012)
Biotech with late-stage clinical program. US headquarter
International Team Leader & Senior Director Project Management, Reporting to SVP Regulatory Affairs
GPC Biotech AG, Martinsried, Germany (1998-2008)
From start-up to established biotech. Headquarter in Martinsried, Germany. 2 US sites.
Senior Director Project Management, Reporting to CSO, 2002-2008
Head of Microbiology, 1998-2002
Glaxo Wellcome (now GSK), Geneva, Switzerland (1997-1998)
Research Scientist & Group Leader Microbial Genomics, 1997-1998
Academic Experience
EMBO Fellow, Karolinska Institute, Stockholm, Sweden (1995-1996)
Assistant Researcher, Swiss Federal Institute of Technology (ETH), Zürich, Switzerland (1994-1995)
Awards
ETH Medal
